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labelling of the A and the D-form of complex I in SMP. After
reduction-induced chemical proteolysis of surrounding proteins by
Fe(II)-chelate, complex I was isolated and subunits were separated by
2D SDS PAGE. In an additional experiment, in order to label primary
amines accessible in both enzyme molecules we used ﬂuorescent
NHS-esters to identify any conformational difference between the A
and the D-form.
The differential labelling of complex I provided new information
on the structural differences between the two forms of the enzyme.
Physiological consequences of de-activation and possible regulatory
modiﬁcations that target one of the forms physiologically are
discussed.
References
[1] A. Galkin, B. Meyer, I. Wittig, M. Karas, H. Schagger, A.A.
Vinogradov, U. Brandt, J. Biol. Chem. 283 (2008) 20907–20913.
[2] I. Wittig, R. Carrozzo, F. Santorelli, H. Schagger, Biochim.
Biophys. Acta 1757 (2006) 1066–1072.
doi:10.1016/j.bbabio.2012.06.143
6P4
A novel chaperone-like subunit of complex I from
Thermus thermophilus
Rozbeh Baradaran, Leonid A. Sazanov
Medical Research Council Mitochondrial Biology Unit, UK
E-mail: rb2@mrc-mbu.cam.ac.uk
NADH-ubiquinone oxidoreductase (complex I) is the ﬁrst and the
largest enzyme in the respiratory chain of mitochondria and most
bacteria. Complex I catalyses the transfer of two electrons from NADH
to quinone, coupled to the translocation of about four protons across
the membrane. The mitochondrial enzyme contains 45 different
subunits, while the bacterial enzyme consists of 13–15 different
subunits. Analogues of all conserved bacterial subunits are found in
the mitochondrial enzyme. We study bacterial complex I as a
“minimal” model of the mitochondrial enzyme. It is an L-shaped
assembly, with the hydrophobic arm embedded in the membrane and
the hydrophilic arm protruding into the bacterial cytoplasm.
Recently, we have crystallised the entire complex I from Thermus
thermophilus and determined its architecture by molecular replace-
ment with the structures of the hydrophilic and the hydrophobic
domains [1]. We have now identiﬁed a novel T. thermophilus protein
of about 14.2 kDa, which is not part of the nqo operon. This protein is
present in approximately 50% of the total puriﬁed complex I,
depending on the cell growth and conditions. It does not appear to
be necessary for activity, including proton-pumping. However, it is
essential for crystallisation of the intact complex — it is involved in
crystal contacts, and may also stabilise the junction between the two
main domains, as it binds to the hydrophilic arm close to the
hydrophobic domain. Although there are many chaperones/assembly
factors known for the mitochondrial complex I, this is the ﬁrst case of
a chaperone-like protein described for bacterial complex I.
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Type II or alternative NADH dehydrogenases (NDH-II) are
monomeric enzymes with a molecular mass of ≈50 kDa containing
FAD as the only prosthetic group. They are membrane associated
proteins that catalyse NADH:quinone oxidoreduction but do not
directly contribute to the establishment of the membrane potential.
NDHs-II are present in the three domains of life. In eukaryotes,
their presence has been observed in plants, fungi and protozoa. In
several organisms, especially in pathogenic such as Staphylococcus
aureus, only NDH-II is expressed, which raises the possibility for
rational design of speciﬁc drugs interacting at the level of this
enzyme, which is not present in animal mitochondria. Furthermore,
NDHs-II have been suggested to be used in gene therapy correcting
NADH:quinone oxidoreductase activity in pathologies with
malfunctioning complex I such as neurodegenerative disorders. Thus,
not only for its importance in bioenergetics, but also in other areas
such as health a deep knowledge of NDH-II is demanded.
Although being a simple enzyme and having been isolated for the
ﬁrst time more than thirty years ago, fundamental questions
regarding its structural/functional relation are still unanswered. Its
structure, the substrate binding sites, and its membrane association
mode are still unknown. Also its functional mechanism has to be
investigated, namely concerning the interaction with the substrates
and the way FAD is reduced by NADH and oxidised by the quinone.
In this work conformational changes in NDH-II from Escherichia
coli due to interactions with its substrates (NADH and quinone) were
monitored. For that, changes in the ﬂuorescence of tryptophan
residues in response to ligand binding were followed. In order to
identify the structural elements/motifs involved in substrate interac-
tion, surface enhanced infrared absorption (SEIRA) spectroscopy was
applied.
It was observed that the protein reacts with NADH and with
different quinones promoting the interaction of the ubiquinone
analogue, apparently, more pronounce conformational changes. The
involvement of Trp and Glu/Asn residues in the binding of NADH and
ubiquinone is suggested. The obtained results prompt us to extend
the project to the study of NDHs-II from organisms that synthesize
different quinones. A comparative study showing the differences
between ubiquinone and menaquinone bindings will be showed.
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